Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of IHL-305 (Irinotecan Liposome Injection) to Treat Advanced Solid Tumors
This study is currently recruiting participants.
Study NCT00364143. Last updated on April 6, 2007.
Information provided by Yakult Honsha Co., LTD
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Cancer
Additional drug interventions recognized in this trial
Irinotecan
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Phytogenic
Enzyme Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
Yakult Honsha Co., LTD
Back to top of Main Content